James A. Wells, Ph.D.
Affiliations: | Pharmaceutical Chemistry | University of California, San Francisco, San Francisco, CA |
Area:
molecular recognitionWebsite:
http://profiles.ucsf.edu/james.wellsGoogle:
"James Wells, UCSF"Bio:
http://www.nasonline.org/member-directory/members/3008577.html
http://wellslab.ucsf.edu
http://cancer.ucsf.edu/people/profiles/wells_james.3746
Mean distance: 8.74 | S | N | B | C | P |
Parents
Sign in to add mentor| Ralph G. Yount | grad student | 1979 | WSU | |
| (Inactivation of myosin subfragment-one by Cobalt(II)/Co(III) phenanthroline complexes) | ||||
| George R. Stark | post-doc | 1982 | Stanford Medical School | |
Children
Sign in to add trainee| Debajyoti Datta | grad student | 2010 | UCSF |
| Daniel C. Gray | grad student | 2011 | UCSF |
| Christopher L. McClendon | grad student | 2011 | UCSF |
| Emily D. Crawford | grad student | 2012 | UCSF |
| Julie A. Zorn | grad student | 2012 | UCSF |
| Charles W Morgan | grad student | 2008-2015 | |
| David Y. Jackson | post-doc | Genentech, Inc. | |
| Amy Weeks | post-doc | UCSF | |
| Zachary B. Hill | post-doc | 2012- | UCSF |
| Michelle R. Arkin | post-doc | 1997-1998 | Genentech, Inc. |
| Gregory Alan Weiss | post-doc | 1998-2000 | Genentech |
| Hikari A. I. Yoshihara | post-doc | 2005-2009 | |
| Dennis W. Wolan | post-doc | 2005-2010 | UCSF |
| Wentao Chen | post-doc | 2016-2019 | UCSF |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schaefer K, Lui I, Byrnes JR, et al. (2022) Direct Identification of Proteolytic Cleavages on Living Cells Using a Glycan-Tethered Peptide Ligase. Acs Central Science. 8: 1447-1456 |
| Jiang Z, Kuo YH, Zhong M, et al. (2022) Adaptor-Specific Antibody Fragment Inhibitors for the Intracellular Modulation of p97 (VCP) Protein-Protein Interactions. Journal of the American Chemical Society |
| Byrnes JR, Weeks AM, Shifrut E, et al. (2022) Hypoxia is a dominant remodeler of the effector T cell surface proteome relative to activation and regulatory T cell suppression. Molecular & Cellular Proteomics : McP. 100217 |
| Martinko AJ, Simonds EF, Prasad S, et al. (2022) Switchable assembly and function of antibody complexes in vivo using a small molecule. Proceedings of the National Academy of Sciences of the United States of America. 119 |
| Weeks AM, Byrnes JR, Lui I, et al. (2021) Mapping proteolytic neo-N termini at the surface of living cells. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Chen W, Mou KY, Solomon P, et al. (2021) Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 118 |
| Lim SA, Wells JA. (2020) Split enzymes: Design principles and strategy. Methods in Enzymology. 644: 275-296 |
| Zhou X, Bracken C, Zhang K, et al. (2020) Targeting phosphotyrosine in native proteins with conditional, bi-specific antibody traps. Journal of the American Chemical Society |
| Lim DC, Joukov V, Rettenmaier TJ, et al. (2020) Redox priming promotes Aurora A activation during mitosis. Science Signaling. 13 |
| Harvey EP, Hauseman ZJ, Cohen DT, et al. (2020) Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering. Cell Chemical Biology |